A detailed history of Oppenheimer Asset Management Inc. transactions in Natera, Inc. stock. As of the latest transaction made, Oppenheimer Asset Management Inc. holds 24,464 shares of NTRA stock, worth $4.09 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
24,464
Previous 20,197 21.13%
Holding current value
$4.09 Million
Previous $2.19 Million 42.16%
% of portfolio
0.04%
Previous 0.03%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$97.75 - $129.67 $417,099 - $553,301
4,267 Added 21.13%
24,464 $3.11 Million
Q2 2024

Aug 08, 2024

BUY
$85.28 - $112.6 $222,666 - $293,998
2,611 Added 14.85%
20,197 $2.19 Million
Q1 2024

May 06, 2024

BUY
$59.21 - $92.9 $232,517 - $364,818
3,927 Added 28.75%
17,586 $1.61 Million
Q4 2023

Feb 13, 2024

BUY
$37.55 - $62.64 $57,977 - $96,716
1,544 Added 12.74%
13,659 $855,000
Q3 2023

Nov 07, 2023

BUY
$43.4 - $62.52 $89,100 - $128,353
2,053 Added 20.4%
12,115 $536,000
Q2 2023

Aug 02, 2023

SELL
$47.08 - $55.16 $2,259 - $2,647
-48 Reduced 0.47%
10,062 $489,000
Q1 2023

May 10, 2023

BUY
$36.57 - $58.29 $37,849 - $60,330
1,035 Added 11.4%
10,110 $561,000
Q4 2022

Feb 06, 2023

BUY
$34.17 - $47.91 $27,677 - $38,807
810 Added 9.8%
9,075 $364,000
Q3 2022

Nov 14, 2022

BUY
$36.93 - $56.68 $305,226 - $468,460
8,265 New
8,265 $362,000
Q2 2022

Aug 08, 2022

SELL
$28.13 - $44.54 $155,249 - $245,816
-5,519 Closed
0 $0
Q1 2022

May 12, 2022

SELL
$30.32 - $91.33 $491,638 - $1.48 Million
-16,215 Reduced 74.61%
5,519 $225,000
Q4 2021

Feb 02, 2022

SELL
$86.26 - $119.0 $271,977 - $375,207
-3,153 Reduced 12.67%
21,734 $2.03 Million
Q3 2021

Nov 12, 2021

BUY
$100.17 - $126.36 $247,419 - $312,109
2,470 Added 11.02%
24,887 $2.77 Million
Q2 2021

Aug 03, 2021

BUY
$86.05 - $119.72 $109,283 - $152,044
1,270 Added 6.01%
22,417 $2.55 Million
Q1 2021

May 17, 2021

BUY
$91.47 - $124.36 $295,996 - $402,428
3,236 Added 18.07%
21,147 $2.15 Million
Q4 2020

Feb 11, 2021

BUY
$66.66 - $111.74 $323,301 - $541,939
4,850 Added 37.13%
17,911 $1.78 Million
Q3 2020

Nov 13, 2020

BUY
$45.89 - $72.67 $290,896 - $460,655
6,339 Added 94.3%
13,061 $944,000
Q2 2020

Aug 11, 2020

BUY
$26.36 - $49.86 $117,486 - $222,226
4,457 Added 196.78%
6,722 $336,000
Q1 2020

May 08, 2020

BUY
$17.27 - $40.17 $26,215 - $60,978
1,518 Added 203.21%
2,265 $68,000
Q4 2019

Feb 07, 2020

SELL
$32.1 - $40.4 $2,921 - $3,676
-91 Reduced 10.86%
747 $25,000
Q3 2019

Oct 31, 2019

BUY
$25.38 - $34.89 $4,238 - $5,826
167 Added 24.89%
838 $27,000
Q2 2019

Aug 09, 2019

BUY
$17.75 - $27.58 $3,283 - $5,102
185 Added 38.07%
671 $19,000
Q1 2019

Apr 24, 2019

BUY
$11.34 - $20.62 $1,519 - $2,763
134 Added 38.07%
486 $10,000
Q4 2018

Jan 30, 2019

BUY
$12.32 - $24.38 $4,336 - $8,581
352 New
352 $5,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.2B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Oppenheimer Asset Management Inc. Portfolio

Follow Oppenheimer Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.